These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Saha RN; Pahan K Cell Death Differ; 2006 Apr; 13(4):539-50. PubMed ID: 16167067 [TBL] [Abstract][Full Text] [Related]
4. Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Selvi BR; Cassel JC; Kundu TK; Boutillier AL Biochim Biophys Acta; 2010; 1799(10-12):840-53. PubMed ID: 20833281 [TBL] [Abstract][Full Text] [Related]
13. HDACs and HDAC Inhibitors in Cancer Development and Therapy. Li Y; Seto E Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530 [TBL] [Abstract][Full Text] [Related]
14. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Langley B; Gensert JM; Beal MF; Ratan RR Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):41-50. PubMed ID: 15723612 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Harrison IF; Dexter DT Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791 [TBL] [Abstract][Full Text] [Related]
16. A role for histone deacetylases in the cellular and behavioral mechanisms underlying learning and memory. Mahgoub M; Monteggia LM Learn Mem; 2014 Oct; 21(10):564-8. PubMed ID: 25227251 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise. Mai A; Rotili D; Valente S; Kazantsev AG Curr Pharm Des; 2009; 15(34):3940-57. PubMed ID: 19751207 [TBL] [Abstract][Full Text] [Related]
19. The role of altered protein acetylation in neurodegenerative disease. Kabir F; Atkinson R; Cook AL; Phipps AJ; King AE Front Aging Neurosci; 2022; 14():1025473. PubMed ID: 36688174 [TBL] [Abstract][Full Text] [Related]
20. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Rossaert E; Pollari E; Jaspers T; Van Helleputte L; Jarpe M; Van Damme P; De Bock K; Moisse M; Van Den Bosch L Acta Neuropathol Commun; 2019 Jul; 7(1):107. PubMed ID: 31277703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]